Journal of the American Heart Association · 12 Nov 2026
Predictors of Clinically Meaningful 1‐Year Health Status Improvements Following Endovascular or Surgical Revascularization: Insights From the BEST‐CLI Trial
Kim G. Smolderenh-index 31, Matthew Menard, Alik Farber, Mufti M. Rahman, Kenneth Rosenfield, Michael Strong, Gheorghe Doros, Philip Goodney, Samir K. Shah, Richard R. Powell, Bjoern Suckow, Kim Houland, Jeffrey Siracuse, Gaëlle Romain, Jacob Cleman, Lindsey Scierka, Carlos Mena‐Hurtadoh-index 17
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
- Europe PMC0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
Background Despite efforts to promote limb salvage in chronic limb‐threatening ischemia (CLTI), the factors associated with meaningful health status improvement after revascularization remain poorly understood. We examined predictors of meaningful 1‐year health status improvement following revascularization for CLTI. Methods We pooled endovascular and surgical arms from the BEST‐CLI (Best Endovascular Versus Best Surgical Therapy in Patients With CLTI) randomized controlled trial, including patients with CLTI (150 international sites, 2014–2019). Health status was assessed at baseline and 1 year using the peripheral artery disease‐specific Vascular Quality of Life questionnaire, the generic European Quality‐of‐Life 5 Dimensions, and the Short Form‐12 Physical and Mental Component Summary. Distribution‐based minimal clinically important difference thresholds were defined as 0.5 SD of baseline health status scores. Multivariable logistic regression identified predictors of no meaningful 1‐year improvement (same/worsened versus improved). Results Among 1017 patients (72.0% men, mean age 66.8±9.7 years), clinically meaningful improvements were reported by 76.5% for Vascular Quality of Life, 52.8% European Quality‐of‐Life 5 Dimensions, 56.7% for Short Form‐12 Physical Component Summary, and 42.1% for Short Form‐12 Mental Component Summary, regardless of revascularization type (surgical versus endovascular). Cardiometabolic risk factors and higher preprocedural health status increased the odds of no meaningful improvement. Revascularization type was not associated with Vascular Quality of Life improvement (odds ratio, 1.059 [95% CI, 0.91–1.23]; P =0.445; C statistic=0.77). Conclusions One‐year postrevascularization, over three‐fourths of individuals with CLTI perceived meaningful improvements in peripheral artery disease‐specific health, and over half improved overall physical health, regardless of procedure type. Cardiometabolic risk factors and higher preprocedural health status predicted 1‐year health status response. REGISTRATION: URL: https://clinicaltrials.gov ; Unique identifier: NCT02060630
What the data shows
- No database records a citation yet, as is usual for a paper this new.
- Kim G. Smolderen has the highest h-index among the authors (31).
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (46)
What it cites, from open citation data, with Crossref's record of each.
Sign in to see 26 more references
A free account opens the rest of the citing papers and references on every paper’s page.